Cargando…
Clinical significance of Janus Kinase inhibitor selectivity
Cytokines are key drivers of inflammation in RA, and anti-cytokine therapy has improved the outcome of RA. Janus Kinases (JAK) are intracellular tyrosine kinases linked to intracellular domains of many cytokine receptors. There are four JAK isoforms: JAK1, JAK2, JAK3 and TYK2. Different cytokine rec...
Autor principal: | Choy, Ernest H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532440/ https://www.ncbi.nlm.nih.gov/pubmed/30508136 http://dx.doi.org/10.1093/rheumatology/key339 |
Ejemplares similares
-
Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019) -
Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012) -
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019) -
Role of Janus Kinase Inhibitors in Therapy of Psoriasis
por: Słuczanowska-Głąbowska, Sylwia, et al.
Publicado: (2021) -
Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)